pd 98059 has been researched along with Placental-Site Trophoblastic Tumor in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Köbel, M | 1 |
| Pohl, G | 1 |
| Schmitt, WD | 1 |
| Hauptmann, S | 1 |
| Wang, TL | 1 |
| Shih, IeM | 1 |
1 other study available for pd 98059 and Placental-Site Trophoblastic Tumor
| Article | Year |
|---|---|
Activation of mitogen-activated protein kinase is required for migration and invasion of placental site trophoblastic tumor.
Topics: Benzamides; Case-Control Studies; Cell Movement; Cells, Cultured; Enzyme Activation; Female; Flavono | 2005 |